Radiopharmaceuticals Market By Type (Diagnostic {SPECT, PET, and, Others} and Therapeutic {Alpha Emitters, Beta Emitters, Neutron Capture Therapy (NCT), and Others}), By Radioisotope (Technetium-99m, Fluorine-18, Iodine-131, Lutetium-177, Gallium-68, and Others), By Application (Oncology, Cardiology, Neurology, Orthopedics, Infectious Diseases, and Others), By Source (Nuclear Reactors and Cyclotrons), and By End-user (Hospitals, Diagnostic Imaging Centers, Cancer Treatment Centers, and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Type

• Diagnostic
  • SPECT
  • PET
  • Others
• Therapeutic
  • Alpha Emitters
  • Beta Emitters
  • Neutron Capture Therapy (NCT)
  • Others

By Radioisotope

• Technetium-99m
• Fluorine-18
• Iodine-131
• Lutetium-177
• Gallium-68
• Others

By Application

• Oncology
• Cardiology
• Neurology
• Orthopedics
• Infectious Diseases
• Others

By Source

• Nuclear Reactors
• Cyclotrons

By End-user

• Hospitals
• Diagnostic Imaging Centers
• Cancer Treatment Centers
• Research Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• GE Healthcare
• Siemens Healthineers
• Cardinal Health
• Bayer AG
• Eli Lilly and Company
• Novartis
• Thermo Fisher Scientific
• United Radiopharmaceuticals
• Telix Pharmaceuticals
• Lantheus Medical Imaging
• NorthStar Medical Radioisotopes
• Advanced Accelerator Applications (AAA)
• Isologic Innovative Radiopharmaceuticals
• Bracco Imaging
• Ion Beam Applications (IBA)